Chatham Capital Group, Inc. Spdr Ser Tr Spdr S&P Biotech E Transaction History
Chatham Capital Group, Inc.
- $595 Million
- Q4 2024
A detailed history of Chatham Capital Group, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 5,078 shares of XBI stock, worth $442,446. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,078
Previous 6,378
20.38%
Holding current value
$442,446
Previous $630,000
27.46%
% of portfolio
0.08%
Previous 0.1%
Shares
27 transactions
Others Institutions Holding XBI
# of Institutions
916Shares Held
102MCall Options Held
27.4MPut Options Held
38.6M-
Citigroup Inc11.2MShares$972 Million0.62% of portfolio
-
Morgan Stanley New York, NY10.2MShares$886 Million0.07% of portfolio
-
Goldman Sachs Group Inc New York, NY9.56MShares$833 Million0.14% of portfolio
-
Bank Of America Corp Charlotte, NC8.52MShares$742 Million0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY8.01MShares$698 Million0.06% of portfolio